Bio-Techne Corporation (TECH)
NASDAQ: TECH · IEX Real-Time Price · USD
75.46
-0.46 (-0.61%)
At close: Jul 19, 2024, 4:00 PM
75.55
+0.09 (0.12%)
Pre-market: Jul 20, 2024, 9:28 AM EDT
Bio-Techne Revenue
Bio-Techne had revenue of $1.15B in the twelve months ending March 31, 2024, with 2.73% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $303.43M with 3.16% year-over-year growth. In the fiscal year ending June 30, 2023, Bio-Techne had annual revenue of $1.14B with 2.81% growth.
Revenue (ttm)
$1.15B
Revenue Growth
+2.73%
P/S Ratio
10.30
Revenue / Employee
$378,453
Employees
3,050
Market Cap
11.89B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2023 | 1.14B | 31.10M | 2.81% |
Jun 30, 2022 | 1.11B | 174.57M | 18.75% |
Jun 30, 2021 | 931.03M | 192.34M | 26.04% |
Jun 30, 2020 | 738.69M | 24.69M | 3.46% |
Jun 30, 2019 | 714.01M | 71.01M | 11.04% |
Jun 30, 2018 | 642.99M | 79.99M | 14.21% |
Jun 30, 2017 | 563.00M | 63.98M | 12.82% |
Jun 30, 2016 | 499.02M | 46.78M | 10.34% |
Jun 30, 2015 | 452.25M | 94.48M | 26.41% |
Jun 30, 2014 | 357.76M | 47.19M | 15.19% |
Jun 30, 2013 | 310.58M | -3.99M | -1.27% |
Jun 30, 2012 | 314.56M | 24.60M | 8.48% |
Jun 30, 2011 | 289.96M | 20.92M | 7.77% |
Jun 30, 2010 | 269.05M | 5.09M | 1.93% |
Jun 30, 2009 | 263.96M | 6.54M | 2.54% |
Jun 30, 2008 | 257.42M | 33.94M | 15.19% |
Jun 30, 2007 | 223.48M | 20.87M | 10.30% |
Jun 30, 2006 | 202.62M | 23.97M | 13.41% |
Jun 30, 2005 | 178.65M | 17.40M | 10.79% |
Jun 30, 2004 | 161.26M | 16.25M | 11.20% |
Jun 30, 2003 | 145.01M | 14.11M | 10.78% |
Jun 30, 2002 | 130.90M | 15.54M | 13.47% |
Jun 30, 2001 | 115.36M | 11.52M | 11.09% |
Jun 30, 2000 | 103.84M | 12.94M | 14.23% |
Jun 30, 1999 | 90.90M | 23.61M | 35.09% |
Jun 30, 1998 | 67.29M | 6.37M | 10.45% |
Jun 30, 1997 | 60.92M | 6.33M | 11.60% |
Jun 30, 1996 | 54.59M | 6.87M | 14.40% |
Jun 30, 1995 | 47.72M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Fresenius Medical Care AG & Co. KGaA | 21.17B |
Universal Health Services | 14.66B |
DaVita | 12.34B |
Smith & Nephew | 5.55B |
Catalent | 4.14B |
Charles River Laboratories International | 4.11B |
Dr. Reddy's Laboratories | 3.35B |
Royalty Pharma | 2.24B |
TECH News
- 7 days ago - BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 7, 2024, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2024 FINANCIAL RESULTS - PRNewsWire
- 7 weeks ago - BIO-TECHNE TO PRESENT AT UPCOMING INVESTOR CONFERENCES - PRNewsWire
- 7 weeks ago - BIO-TECHNE TO HIGHLIGHT MULTIPLE APPLICATIONS OF THE MauriceFlex™ SYSTEM AT THE ANNUAL ASMS CONFERENCE - PRNewsWire
- 7 weeks ago - ScaleReady Announces $20 Million G-Rex® Grant Program for the Advancement of Cell and Gene Therapy (CGT) Development and Manufacturing - PRNewsWire
- 2 months ago - BIO-TECHNE TO PRESENT AT THE 2024 LEERINK PARTNERS HEALTHCARE CROSSROADS CONFERENCE - PRNewsWire
- 2 months ago - BIO-TECHNE HIGHLIGHTS RECENTLY ANNOUNCED TOP-LINE BIOMARKER DATA FROM PARTNER, REGULUS THERAPEUTICS, USING THE COMPANY'S PROPRIETARY TECHNOLOGY - PRNewsWire
- 2 months ago - Court Revokes Two Advanced Cell Diagnostics Patents, Dismisses Infringement Claims Against Molecular Instruments and Orders Advanced Cell Diagnostics to Make Payment of £1.35 Million to Molecular Instruments - Business Wire
- 2 months ago - BIO-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTH CARE CONFERENCE 2024 - PRNewsWire